Grants & Research
Ampersand Biosciences’ scientific team has decades of cumulative experience driving progress in pharmaceutical research. These selected grants and papers highlight some of our work.
Grants
This SBIR grant, awarded in 2020 to Ampersand Biosciences and principal investigator Tori Race, addressed a pressing need to develop reagents to better understand and describe the immune response to infection and support biomarker and countermeasure development through immunologic analyses of respiratory infections in the ferret.
This ongoing SBIR grant, awarded in 2022 to Ampersand Biosciences and principal investigator Tori Race, seeks to produce and test monoclonal antibodies against 10 cytokines and chemokines and 4 T cell surface markers for characterizing cytokine responses and examining T cells activation in the hamster models of respiratory infection.
Publications
Ampersand Biosciences is a leader in assay validation.
Khan MU, Bowsher RR, Cameron M, Devanarayan V, Keller S, King L, Lee J, Morimoto A, Rhyne P, Stephen L, Wu Y, Wyant T, Lachno DR. Bioanalysis. 2015; 7(2):229-42.
Khan MU, Bowsher RR, Cameron M, Devanarayan V, Keller S, King L, Lee J, Morimoto A, Rhyne P, Stephen L, Wu Y, Wyant T, Lachno DR. Bioanalysis. 2015; 7(2):229-42.
Clients rely on us to develop panels that lead to groundbreaking discoveries.
Kobayashi DT, Shi J, Stephen L, Ballard KL, Dewey R, Mapes J, Chung B, McCarthy K, Swoboda KJ, Crawford TO, Li R, Plasterer T, Joyce C; Biomarkers for Spinal Muscular Atrophy Study Group, Chung WK, Kaufmann P, Darras BT, Finkel RS, Sproule DM, Martens WB, McDermott MP, De Vivo DC; Walker MG, Chen KS. PLoS One. 2013; 8(4):e60113.
Srivastava AK, Jaganathan S, Stephen L, Hollingshead MG, Layhee A, Damour E, Govindharajulu JP, Donohue J, Esposito D, Mapes JP, Kinders RJ, Takebe N, Tomaszewski JE, Kummar S, Doroshow JH, Parchment RE. Clinical Cancer Research. 2016 22(4):1000-10.